Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Contrast Agents Regain ‘Drug’ Status, But Ophthalmic Products Still Subject To Genus Decision
Jan 04 2023
•
By
Brenda Sandburg
Certain products to be regulated as drugs rather than as devices under omnibus year-end legislation. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Legal & IP
More from Pink Sheet